The treatment modalities for CRC include surgery, radiation therapy, and systemic treatments such as chemotherapy, immunotherapy, and targeted therapy including the anti-EGFR (epidermal growth factor receptor) agent cetuximab and the anti-angiogenesis agent bevacizumab. The gene discussed is EGFR; the disease is colorectal carcinoma.